R Ram Upadhayaya News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Delhi [India], June 6 (ANI): Council of Scientific and Industrial Research (CSIR) along and Laxai Life Sciences Pvt. Ltd. on Sunday initiated Phase-II clinical trial for anti-helminitic drug Niclosamide for treatment of Covid-19.

Andhra pradeshNew delhiSrivari chandrashekharRam upadhayayaShekharc mandeLaxai life sciences pvtCouncil of scientificLaxai life sciencesIndustrial researchDirector generalActive pharmaceutical ingredientR shekharc mandeR ram upadhayayaPhase ii clinical trialஆந்திரா பிரதேஷ்புதியது டெல்ஹி